H4C7
gene geneOn this page
Also known as H4/l
Summary
H4C7 (H4 clustered histone 7, HGNC:4792) is a protein-coding gene on chromosome 6p22.2, encoding Histone H4-like protein type G (Q99525). Core component of nucleosome.
Histones are basic nuclear proteins that are responsible for the nucleosome structure of the chromosomal fiber in eukaryotes. Two molecules of each of the four core histones (H2A, H2B, H3, and H4) form an octamer, around which approximately 146 bp of DNA is wrapped in repeating units, called nucleosomes. The linker histone, H1, interacts with linker DNA between nucleosomes and functions in the compaction of chromatin into higher order structures. This gene is intronless and encodes a replication-dependent histone that is a member of the histone H4 family. Transcripts from this gene lack polyA tails but instead contain a palindromic termination element. This gene is found in the large histone gene cluster on chromosome 6.
Source: NCBI Gene 8369 — RefSeq curated summary.
At a glance
- GWAS associations: 17
- Clinical variants (ClinVar): 29 total
- MANE Select transcript:
NM_003547
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4792 |
| Approved symbol | H4C7 |
| Name | H4 clustered histone 7 |
| Location | 6p22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | H4/l |
| Ensembl gene | ENSG00000275663 |
| Ensembl biotype | protein_coding |
| OMIM | 602832 |
| Entrez | 8369 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000611444
RefSeq mRNA: 1 — MANE Select: NM_003547
NM_003547
CCDS: CCDS4599
Canonical transcript exons
ENST00000611444 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003754862 | 26246611 | 26246996 |
Expression profiles
Bgee: expression breadth broad, 11 present calls, max score 59.37.
Top tissues by expression
254 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibialis anterior | UBERON:0001385 | 59.37 | silver quality |
| decidua | UBERON:0002450 | 56.55 | gold quality |
| cranial nerve II | UBERON:0000941 | 55.99 | gold quality |
| ileal mucosa | UBERON:0000331 | 54.26 | silver quality |
| deltoid | UBERON:0001476 | 53.34 | silver quality |
| hair follicle | UBERON:0002073 | 52.43 | gold quality |
| triceps brachii | UBERON:0001509 | 52.21 | gold quality |
| quadriceps femoris | UBERON:0001377 | 49.37 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 49.11 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 48.78 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.25 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.00 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 47.80 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.70 | gold quality |
| thymus | UBERON:0002370 | 47.42 | gold quality |
| periodontal ligament | UBERON:0008266 | 47.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.81 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- A novel histone H4 variant H4G regulates ribosomal DNA transcription in breast cancer. (PMID:31219579)
Cross-species orthologs
19 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | His4:CG33875 | FBGN0053875 |
| drosophila_melanogaster | His4:CG33889 | FBGN0053889 |
| drosophila_melanogaster | His4:CG33903 | FBGN0053903 |
| caenorhabditis_elegans | WBGENE00001875 | |
| caenorhabditis_elegans | WBGENE00001879 | |
| caenorhabditis_elegans | WBGENE00001884 | |
| caenorhabditis_elegans | WBGENE00001888 | |
| caenorhabditis_elegans | WBGENE00001892 | |
| caenorhabditis_elegans | WBGENE00001900 | |
| caenorhabditis_elegans | WBGENE00001902 | |
| caenorhabditis_elegans | WBGENE00001905 | |
| caenorhabditis_elegans | WBGENE00001911 | |
| caenorhabditis_elegans | WBGENE00001912 | |
| caenorhabditis_elegans | WBGENE00001920 | |
| caenorhabditis_elegans | WBGENE00001924 | |
| caenorhabditis_elegans | WBGENE00001930 | |
| caenorhabditis_elegans | WBGENE00001934 | |
| caenorhabditis_elegans | WBGENE00001938 | |
| caenorhabditis_elegans | his-67 | WBGENE00001941 |
Paralogs (14): H4C8 (ENSG00000158406), H4C3 (ENSG00000197061), H4C11 (ENSG00000197238), H4C16 (ENSG00000197837), H4C15 (ENSG00000270276), H4C14 (ENSG00000270882), H4C12 (ENSG00000273542), H4C6 (ENSG00000274618), H4C13 (ENSG00000275126), H4C9 (ENSG00000276180), H4C5 (ENSG00000276966), H4C4 (ENSG00000277157), H4C1 (ENSG00000278637), H4C2 (ENSG00000278705)
Protein
Protein identifiers
Histone H4-like protein type G — Q99525 (reviewed: Q99525)
Alternative names: H4-clustered histone 7
All UniProt accessions (1): Q99525
UniProt curated annotations — full annotation on UniProt →
Function. Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling.
Subunit / interactions. The nucleosome is a histone octamer containing two molecules each of H2A, H2B, H3 and H4 assembled in one H3-H4 heterotetramer and two H2A-H2B heterodimers. The octamer wraps approximately 147 bp of DNA.
Subcellular location. Nucleus. Chromosome.
Similarity. Belongs to the histone H4 family.
RefSeq proteins (1): NP_003538* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001951 | Histone_H4 | Family |
| IPR009072 | Histone-fold | Homologous_superfamily |
UniProt features (2 total): chain 1, DNA-binding region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q99525-F1 | 87.89 | 0.72 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
GOBP_PROTEIN_DNA_COMPLEX_ORGANIZATION, GOBP_CHROMATIN_REMODELING, DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP, GOCC_PROTEIN_DNA_COMPLEX, IRF2_01, GOMF_PROTEIN_HETERODIMERIZATION_ACTIVITY, GOMF_PROTEIN_DIMERIZATION_ACTIVITY, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, GOBP_NUCLEOSOME_ORGANIZATION, IRF1_01, WP_HISTONE_MODIFICATIONS, GAL_LEUKEMIC_STEM_CELL_DN, GOCC_NUCLEOSOME, GOMF_STRUCTURAL_CONSTITUENT_OF_CHROMATIN, GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN
GO Biological Process (1): nucleosome assembly (GO:0006334)
GO Molecular Function (4): DNA binding (GO:0003677), structural constituent of chromatin (GO:0030527), protein heterodimerization activity (GO:0046982), protein binding (GO:0005515)
GO Cellular Component (3): nucleosome (GO:0000786), nucleus (GO:0005634), chromosome (GO:0005694)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chromatin | 2 |
| chromatin organization | 1 |
| nucleosome organization | 1 |
| protein-DNA complex assembly | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| protein dimerization activity | 1 |
| binding | 1 |
| protein-DNA complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
3096 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| H4C7 | H2AC20 | Q16777 | 999 |
| H4C7 | H2AC19 | P20670 | 999 |
| H4C7 | H3-3A | P06351 | 998 |
| H4C7 | H3C14 | Q71DI3 | 998 |
| H4C7 | H3-4 | Q16695 | 998 |
| H4C7 | H3-5 | Q6NXT2 | 997 |
| H4C7 | H3C1 | P02295 | 997 |
| H4C7 | H2BC21 | Q16778 | 997 |
| H4C7 | H3-7 | Q5TEC6 | 997 |
| H4C7 | BRD4 | O60885 | 993 |
| H4C7 | BRDT | Q58F21 | 986 |
| H4C7 | RBBP4 | P31149 | 985 |
| H4C7 | TP53BP1 | Q12888 | 979 |
| H4C7 | BRD2 | P25440 | 979 |
| H4C7 | HJURP | Q8NCD3 | 973 |
IntAct
29 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| AGTRAP | H4C7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| H4C7 | AGTRAP | psi-mi:“MI:0915”(physical association) | 0.560 |
| H4C7 | FKBP7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAIP1 | H4C7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | H4C7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FGF14 | H4C7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| H4C7 | CIDEB | psi-mi:“MI:0915”(physical association) | 0.560 |
| RHBDD2 | H4C7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| APOC1 | H4C7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| H4C7 | H1-4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| H4C7 | H3C13 | psi-mi:“MI:0915”(physical association) | 0.400 |
| HMGN1 | H2AX | psi-mi:“MI:0914”(association) | 0.350 |
| HMGN1 | IPO7 | psi-mi:“MI:0914”(association) | 0.350 |
| TMED8 | H4C7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAIP1 | H4C7 | psi-mi:“MI:0915”(physical association) | 0.000 |
| H4C7 | FGF14 | psi-mi:“MI:0915”(physical association) | 0.000 |
| H4C7 | CIDEB | psi-mi:“MI:0915”(physical association) | 0.000 |
| H4C7 | RHBDD2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| H4C7 | APOC1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (41): AGTRAP (Two-hybrid), HIST1H4G (Affinity Capture-MS), HIST1H4G (Two-hybrid), HIST1H4G (Two-hybrid), HIST1H4G (Two-hybrid), HIST1H4G (Two-hybrid), HIST1H4G (Two-hybrid), HIST1H4G (Two-hybrid), HIST1H4G (Two-hybrid), HIST1H4G (Proximity Label-MS), HIST1H4G (Proximity Label-MS), HIST1H4G (Affinity Capture-MS), HIST1H4G (Affinity Capture-MS), HIST1H4G (Affinity Capture-MS), HIST1H4G (Affinity Capture-MS)
ESM2 similar proteins: A0A097I1R9, A0A097I2D0, P02309, P02310, P04915, P08436, P09322, P23750, P23751, P35057, P35059, P40287, P50566, P62786, P62790, P62791, P62792, P62793, P69151, P69152, P70081, P81202, P91849, P91890, Q27443, Q27490, Q41811, Q54BC2, Q54LA5, Q54Z07, Q5M8Q2, Q6LAF1, Q6V9I2, Q6ZXX3, Q71V09, Q757K0, Q75AX1, Q76MU7, Q76NW2, Q8J1L3
Diamond homologs: P02309, P04914, P04915, P08436, P09322, P0CG89, P23750, P23751, P27996, P35057, P35059, P50566, P59259, P62776, P62777, P62778, P62779, P62780, P62781, P62782, P62783, P62784, P62785, P62786, P62787, P62788, P62789, P62792, P62793, P62794, P62795, P62796, P62797, P62798, P62799, P62800, P62801, P62802, P62803, P62804
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
29 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 29 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
48 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:26246694:C:A | donor_gain | 0.8600 |
| 6:26246693:T:TA | donor_gain | 0.6500 |
| 6:26246820:TC:T | acceptor_gain | 0.6500 |
| 6:26246683:A:AC | donor_gain | 0.5800 |
| 6:26246684:C:CC | donor_gain | 0.5800 |
| 6:26246685:A:C | donor_gain | 0.5200 |
| 6:26246774:CCAGA:C | donor_gain | 0.4700 |
| 6:26246851:CGCCA:C | acceptor_gain | 0.4500 |
| 6:26246817:TCCTC:T | acceptor_gain | 0.4400 |
| 6:26246929:TGGC:T | donor_gain | 0.4400 |
| 6:26246712:TAG:T | donor_gain | 0.4100 |
| 6:26246713:AGA:A | donor_gain | 0.4100 |
| 6:26246821:C:CT | acceptor_gain | 0.4100 |
| 6:26246799:T:TG | acceptor_gain | 0.3900 |
| 6:26246908:TCAG:T | donor_gain | 0.3700 |
| 6:26246821:C:A | acceptor_gain | 0.3600 |
| 6:26246909:CAGTA:C | donor_loss | 0.3600 |
| 6:26246910:AGTAC:A | donor_loss | 0.3600 |
| 6:26246911:GTA:G | donor_loss | 0.3600 |
| 6:26246912:TA:T | donor_loss | 0.3600 |
| 6:26246913:A:AT | donor_loss | 0.3600 |
| 6:26246914:CCTT:C | donor_loss | 0.3600 |
| 6:26246915:C:A | donor_loss | 0.3500 |
| 6:26246822:A:C | acceptor_gain | 0.3300 |
| 6:26246928:TTGG:T | donor_gain | 0.3300 |
| 6:26246684:CAGGG:C | donor_gain | 0.3100 |
| 6:26246771:G:T | donor_gain | 0.3100 |
| 6:26246800:TGAAC:T | donor_gain | 0.3100 |
| 6:26246818:CCTCA:C | acceptor_gain | 0.3100 |
| 6:26246800:T:A | acceptor_gain | 0.2900 |
AlphaMissense
622 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:26246792:G:C | F62L | 0.750 |
| 6:26246792:G:T | F62L | 0.750 |
| 6:26246794:A:G | F62L | 0.750 |
dbSNP variants (sampled 300 via entrez): RS1002316739 (6:26246276 G>A,T), RS1003351870 (6:26248016 G>C), RS1003486567 (6:26248303 A>G), RS1004131048 (6:26247994 G>A), RS1005159557 (6:26246301 A>G), RS1005368475 (6:26247134 A>G), RS1005834083 (6:26247394 C>A), RS1006785323 (6:26248346 G>T), RS1007821828 (6:26247041 AC>A), RS1011276476 (6:26246298 A>G), RS1011355118 (6:26246709 A>C), RS1013445555 (6:26248074 C>A), RS1015391874 (6:26247410 C>A,T), RS1015429380 (6:26247700 C>G), RS1015453772 (6:26247489 T>C,G)
Disease associations
OMIM: gene MIM:602832 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
17 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004521_113 | Autism spectrum disorder or schizophrenia | 3.000000e-19 |
| GCST004521_142 | Autism spectrum disorder or schizophrenia | 2.000000e-09 |
| GCST004521_169 | Autism spectrum disorder or schizophrenia | 4.000000e-14 |
| GCST004521_69 | Autism spectrum disorder or schizophrenia | 8.000000e-24 |
| GCST004521_83 | Autism spectrum disorder or schizophrenia | 1.000000e-13 |
| GCST004571_19 | Iron status biomarkers (total iron binding capacity) | 2.000000e-08 |
| GCST004572_27 | Iron status biomarkers (transferrin saturation) | 2.000000e-08 |
| GCST007294_143 | Body fat distribution (trunk fat ratio) | 5.000000e-29 |
| GCST007294_82 | Body fat distribution (trunk fat ratio) | 1.000000e-48 |
| GCST007295_120 | Body fat distribution (leg fat ratio) | 2.000000e-46 |
| GCST007295_91 | Body fat distribution (leg fat ratio) | 1.000000e-26 |
| GCST010002_50 | Refractive error | 4.000000e-34 |
| GCST010083_312 | Hemoglobin levels | 6.000000e-44 |
| GCST010141_1 | Beef consumption | 7.000000e-13 |
| GCST010143_19 | Meat-related diet | 5.000000e-13 |
| GCST010143_31 | Meat-related diet | 7.000000e-09 |
| GCST010143_5 | Meat-related diet | 4.000000e-09 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006334 | total iron binding capacity |
| EFO:0004341 | body fat distribution |
| EFO:0004509 | hemoglobin measurement |
| EFO:0008111 | diet measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| propionaldehyde | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Aldehydes | decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Citrulline | decreases expression | 1 |
| Coal | increases abundance, increases expression | 1 |
| Diethylhexyl Phthalate | increases expression | 1 |
| Lead | increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.